Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cerebral blood flow (CBF) and neuronal membranes refers to a physiological and structural domain rather than a discrete molecular target. Cerebral blood flow is the blood supply to the brain, regulated by myogenic, metabolic, and neurogenic mechanisms to ensure constant delivery of oxygen and nutrients (StatPearls, 2023). Neuronal membranes are the lipid bilayers that maintain ion gradients and host receptors essential for neurotransmission. In the context of pharmacology, agents like vinpocetine or citicoline are often described as targeting these areas to treat stroke or cognitive decline by enhancing perfusion and stabilizing membrane phospholipids (PubMed, 2021). However, because this term lacks a specific protein or genetic identifier, it is considered a broad therapeutic area or physiological state rather than a valid drug target for structured annotation.
Vasodilation of cerebral vessels and stabilization of neuronal lipid bilayers.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cerebral blood flow (CBF) and neuronal membranes (CBF).